RxDoctor Payments Data

Nathan Estes, MD

Clinical Cardiac Electrophysiology · Pittsburgh, PANPI 1619992575

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Boston Scientific at 47.0% of the total. Reporting peaked in 2019 at $28,881 and has fallen 53.2% since, to $13,514 in 2025.

$95,660in general payments, 2019–2025

Across 117 payments — averaging $817.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$45K
  • Medtronic$34K
  • Abbott$16K
  • Irhythm Technologies, Inc.$525
  • Atricure, Inc.$151

What the payments were for

  • Consulting fees$40,71543%
  • Speaking & faculty fees$45,75048%
  • Grants$1470%
  • Travel & lodging$5,2485%
  • Food & beverage$3,8004%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific20$44,921
Medtronic(2 entities)63$34,172
Abbott32$15,891
Irhythm Technologies, Inc.1$525
Atricure, Inc.1$151

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$95,660 in reported general payments places this provider in the 85th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$50,434
Medicare patients
325
Services billed
619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban198$207,336
XareltoRivaroxaban45$34,800
Dofetilide75$20,197
EntrestoSacubitril/Valsartan17$17,494
JardianceEmpagliflozin16$13,797
Amiodarone Hcl96$2,088
Flecainide Acetate29$1,613
Toprol XlMetoprolol Succinate14$1,262
Metoprolol Succinate69$1,051
Spironolactone29$224
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$213
Carvedilol17$112

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →